Tellimer

SG : UG Healthcare Corp Ltd - Too cheap to ignore

3QFY6/21 NP of S$34.3m (a 56-fold increase yoy) was in line, despite logistical disruptions which continued to hamper sales volume. Earnings could continue on an uptrend in 4QFY21, as production capacity growth offsets a gradual decline in ASP. UGHC trades at an undemanding valuation of 5.4x CY22F P/E, and backed by net cash of S$50m. Maintain Add, with a DCF-based TP of S$1.20.


Most Viewed See latest
Disclosures

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...

Full Tellimer disclaimers